Past News

Novel computational pipeline could help repurpose cancer drugs for rare diseases

October 20, 2021

By combining computational and experimental approaches, University of Pittsburgh School of Medicine and Prairie View A&M University researchers identified cancer drugs that show promise for treating pulmonary hypertension, or PH, a rare and incurable lung disease.

Novel computational pipeline could help repurpose cancer drugs for rare diseases

Haller Foundation, Walther Foundation donate $1.5 million to Purdue for endowed professorship in cancer biology

October 20, 2021

A $750,000 donation from the Henry E. Haller Jr. Foundation has endowed a professorship that will support the work of the Purdue Center for Cancer Research and the College of Science in cancer biology. The gift was matched by the Walther Cancer Foundation for a total of $1.5 million. The endowment will be known as the Boyce Haller Professorship.

Haller Foundation, Walther Foundation donate $1.5 million to Purdue for endowed professorship in cancer biology

Amplified Sciences, a life science diagnostic company, named to Most Fundable Companies list

October 19, 2021

Amplified Sciences, a Purdue University-affiliated life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases, has been named to the fourth annual Most Fundable Companies list from Pepperdine University's Graziadio Business School.

Amplified Sciences, a life science diagnostic company, named to Most Fundable Companies list

Purdue University Trustees Ratify Appointment of Dr. Harm HogenEsch as Distinguished Professo

October 8, 2021

Associate Dean for Research Harm HogenEsch is the Purdue University College of Veterinary Medicine’s newest Distinguished Professor. Dr. HogenEsch’s appointment as Distinguished Professor of Immunopathology in the Department of Comparative Pathobiology was ratified by the Purdue University Board of Trustees Friday, October 1, along with three other distinguished professor appointments.

Purdue University Trustees Ratify Appointment of Dr. Harm HogenEsch as Distinguished Professo

What’s in a name? Louisiana lawmakers wrongly say name change scuttles FDA COVID-19 vaccine approval

October 8, 2021

In August, the Food and Drug Administration gave full and final approval to the COVID-19 vaccine developed by Pfizer for people 16 and older. But 10 Republican Louisiana lawmakers allege "there is no FDA approval for the Pfizer BioNTech vaccine for COVID-19."

What’s in a name? Louisiana lawmakers wrongly say name change scuttles FDA COVID-19 vaccine approval

Grain Foods Foundation Welcomes Gut Microbiome Expert Stephen Lindemann, PhD, to Scientific Advisory Board

October 7, 2021

The Grain Foods Foundation announced the addition of Stephen Lindemann, PhD, to its Scientific Advisory Board. Dr. Lindemann is an Associate Professor in the Department of Food Science and a Courtesy Professor in the Departments of Nutrition Science and Biological Sciences at Purdue University.

Grain Foods Foundation Welcomes Gut Microbiome Expert Stephen Lindemann, PhD, to Scientific Advisory Board

Grain Foods Foundation Welcomes Gut Microbiome Expert Stephen Lindemann, PhD, to Scientific Advisory Board

October 7, 2021

The Grain Foods Foundation announced the addition of Stephen Lindemann, PhD, to its Scientific Advisory Board. Dr. Lindemann is an Associate Professor in the Department of Food Science and a Courtesy Professor in the Departments of Nutrition Science and Biological Sciences at Purdue University.

Grain Foods Foundation Welcomes Gut Microbiome Expert Stephen Lindemann, PhD, to Scientific Advisory Board

Scientists reverse the progression of pancreatic cancer with a “time machine” made of human cells

October 1, 2021

What makes pancreatic cancer so deadly is its hidden rapid spread. Today, a “time machine” built by Purdue University engineers shows how to reverse the course of cancer before it spreads throughout the pancreas.

Scientists reverse the progression of pancreatic cancer with a “time machine” made of human cells

‘TIME MACHINE’ REVERSES PANCREATIC CANCER PROGRESSION

October 1, 2021

“These findings open up the possibility of designing a new gene therapy or drug because now we can convert cancerous cells back into their normal state,” says Bumsoo Han, a professor of mechanical engineering at Purdue University and program leader of the Purdue Center for Cancer Research. Han has a courtesy appointment in biomedical engineering.

‘TIME MACHINE’ REVERSES PANCREATIC CANCER PROGRESSION

Smart civil infrastructure could save US billions

September 30, 2021

The United States is in need of a strategic smart-infrastructure plan that integrates digital technology into new projects because inadequately maintained systems can result in “billions of dollars in lost economic productivity,” according to a recent report from Harvard’s Ash Center for Democratic Governance & Innovation.

Smart civil infrastructure could save US billions